Homburger advised ADC Therapeutics SA in its USD 200 m private placement of shares
On October 23, 2017, ADC Therapeutics SA (ADCT), an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it has raised USD 200 m through a private placement of shares. According to BioWorld.com, the placement is the fourth largest private financing round on record for a European biopharmaceutical firm and the second largest private equity round in European biopharma so far in 2017.
Homburger advised ADCT in this matter. The Homburger team is led by partner Dieter Gericke (Corporate | M&A) and included partner Reto Heuberger (Tax), associates Andreas Müller, Daniel Häusermann and Marie Jenny (all Corporate | M&A) as well as junior associate Nicola Mohler.